Market Research Logo

Global Active Pharmaceutical Ingredients (API) Market Analysis 2016 - Forecast to 2022

Global Active Pharmaceutical Ingredients (API) Market Analysis 2016 - Forecast to 2022

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This report analyzes the global markets for "Active Pharmaceutical Ingredients (API)". The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends. Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:

  • Market Sizing estimations and forecasts for a minimum of 6 years of all the given segments, sub segments and the regional markets
  • Identifying market dynamics (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Regional and country level market analysis
  • Competitive landscaping mapping the key common trends
  • Company profiling covering the financials, recent activities and the future strategies
  • Supply chain trends mapping the recent advancements
  • Strategic recommendations for the new entrants


1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations
2 Executive Summary
3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Active Pharmaceutical Ingredient Market by Drug type
5.1 Introduction
5.2 Generic Prescription Drugs
5.3 OTC Prescription Drugs
5.4 Branded Prescription Drugs
6 Active Pharmaceutical Ingredient Market by Therapeutic Area
6.1 Introduction
6.2 Cardiovascular Disease
6.3 Pulmonology
6.4 Diabetes
6.5 Oncology
6.6 Cns and Neurological Disorders
6.7 Orthopedic Disorders
6.8 Nephrology
6.9 Ophthalmology
6.10 Endocrinology
6.11 Gastrointestinal Disorders
6.12 Other therapeutic area
6.12.1 Anesthesia
6.12.2 Eye
6.12.3 ENT
7 Active Pharmaceutical Ingredient Market by Type
7.1 Introduction
7.2 Biological
7.3 Synthetic Chemical
8 Active Pharmaceutical Ingredient Market by Manfacturing Process
8.1 Introduction
8.2 Contract Manufacturing
8.3 Captive Manufacturing
9 Geographical Segmentation
9 .1 North America
9 .1.1 US
9 .1.2 Canada
9 .1.3 Mexico
9 .2 Europe
9 .2.1 Germany
9 .2.2 France
9 .2.3 Italy
9 .2.4 UK
9 .2.5 Spain
9 .3 Asia Pacific
9 .3.1 Japan
9 .3.2 China
9 .3.3 India
9 .3.4 Australia
9 .3.5 New Zealand
9 .3.6 Rest of Asia Pacific
9 .4 RoW
9 .4.1 Latin America
9 .4.2 Middle East
9 .4.3 Africa
9 .4.4 Others
10 Vendor Landscaping
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiles
11.1 Aurobindo Pharma Ltd.
11.1.1 Business Overview
11.1.2 SWOT Analysis
11.1.3 Financial Overview
11.1.4 Strategy
11.1.5 Key Activities
11.2 Dr. Reddy’s Laboratories Ltd.
11.3 Teva Pharmaceutical Industries Limited
11.4 Mylan Inc.
11.5 Sun Pharmaceutical Industries Ltd.
11.6 Lupin
11.7 Allergan PLC
11.8 Novartis International AG
11.9 Albemarle Corporation
11.10 Sigma-Aldrich Corporation
11.11 WuXi AppTec
11.12 BASF SE
11.13 Pfizer, Inc
11.14 Boehringer Ingelheim GmbH
11.15 Ranbaxy
11.16 Boehringer Ingelheim
11.17 Lonza
List of Tables
Table 1 Global Active Pharmaceutical Ingredient Market Analysis, by Region, 2013-2022 ($MN)
Table 2 Global Active Pharmaceutical Ingredient Market Analysis, by Drug Type, 2013-2022 ($MN)
Table 3 Global Generic Prescription Drugs Market Analysis, by Region, 2013-2022 ($MN)
Table 4 Global Generic Prescription Drugs Market Analysis, by Therapeutic Area, 2013-2022 ($MN)
Table 5 Global Generic Prescription Drugs Market Analysis, by Type , 2013-2022 ($MN)
Table 6 Global Generic Prescription Drugs Market Analysis, by Manfacturing Process, 2013-2022 ($MN)
Table 7 Global OTC Prescription Drugs Market Analysis, by Region, 2013-2022 ($MN)
Table 8 Global OTC Prescription Drugs Market Analysis, by Therapeutic Area, 2013-2022 ($MN)
Table 9 Global OTC Prescription Drugs Market Analysis, by Type , 2013-2022 ($MN)
Table 10 Global OTC Prescription Drugs Market Analysis, by Manfacturing Process, 2013-2022 ($MN)
Table 11 Global Branded Prescription Drugs Market Analysis, by Region, 2013-2022 ($MN)
Table 12 Global Branded Prescription Drugs Market Analysis, by Therapeutic Area, 2013-2022 ($MN)
Table 13 Global Branded Prescription Drugs Market Analysis, by Type , 2013-2022 ($MN)
Table 14 Global Branded Prescription Drugs Market Analysis, by Manfacturing Process, 2013-2022 ($MN)
Table 15 Global Active Pharmaceutical Ingredient Market Analysis, by Therapeutic Area, 2013-2022 ($MN)
Table 16 Global Cardiovascular Disease Market Analysis, by Region, 2013-2022 ($MN)
Table 17 Global Cardiovascular Disease Market Analysis, by Drug Type, 2013-2022 ($MN)
Table 18 Global Cardiovascular Disease Market Analysis, by Type , 2013-2022 ($MN)
Table 19 Global Cardiovascular Disease Market Analysis, by Manfacturing Process, 2013-2022 ($MN)
Table 20 Global Pulmonology Market Analysis, by Region, 2013-2022 ($MN)
Table 21 Global Pulmonology Market Analysis, by Drug Type, 2013-2022 ($MN)
Table 22 Global Pulmonology Market Analysis, by Type , 2013-2022 ($MN)
Table 23 Global Pulmonology Market Analysis, by Manfacturing Process, 2013-2022 ($MN)
Table 24 Global Diabetes Market Analysis, by Region, 2013-2022 ($MN)
Table 25 Global Diabetes Market Analysis, by Drug Type, 2013-2022 ($MN)
Table 26 Global Diabetes Market Analysis, by Type , 2013-2022 ($MN)
Table 27 Global Diabetes Market Analysis, by Manfacturing Process, 2013-2022 ($MN)
Table 28 Global Oncology Market Analysis, by Region, 2013-2022 ($MN)
Table 29 Global Oncology Market Analysis, by Drug Type, 2013-2022 ($MN)
Table 30 Global Oncology Market Analysis, by Type , 2013-2022 ($MN)
Table 31 Global Oncology Market Analysis, by Manfacturing Process, 2013-2022 ($MN)
Table 32 Global Cns and Neurological Disorders Market Analysis, by Region, 2013-2022 ($MN)
Table 33 Global Cns and Neurological Disorders Market Analysis, by Drug Type, 2013-2022 ($MN)
Table 34 Global Cns and Neurological Disorders Market Analysis, by Type , 2013-2022 ($MN)
Table 35 Global Cns and Neurological Disorders Market Analysis, by Manfacturing Process, 2013-2022 ($MN)
Table 36 Global Orthopedic Disorders Market Analysis, by Region, 2013-2022 ($MN)
Table 37 Global Orthopedic Disorders Market Analysis, by Drug Type, 2013-2022 ($MN)
Table 38 Global Orthopedic Disorders Market Analysis, by Type , 2013-2022 ($MN)
Table 39 Global Orthopedic Disorders Market Analysis, by Manfacturing Process, 2013-2022 ($MN)
Table 40 Global Nephrology Market Analysis, by Region, 2013-2022 ($MN)
Table 41 Global Nephrology Market Analysis, by Drug Type, 2013-2022 ($MN)
Table 42 Global Nephrology Market Analysis, by Type , 2013-2022 ($MN)
Table 43 Global Nephrology Market Analysis, by Manfacturing Process, 2013-2022 ($MN)
Table 44 Global Ophthalmology Market Analysis, by Region, 2013-2022 ($MN)
Table 45 Global Ophthalmology Market Analysis, by Drug Type, 2013-2022 ($MN)
Table 46 Global Ophthalmology Market Analysis, by Type , 2013-2022 ($MN)
Table 47 Global Ophthalmology Market Analysis, by Manfacturing Process, 2013-2022 ($MN)
Table 48 Global Endocrinology Market Analysis, by Region, 2013-2022 ($MN)
Table 49 Global Endocrinology Market Analysis, by Drug Type, 2013-2022 ($MN)
Table 50 Global Endocrinology Market Analysis, by Type , 2013-2022 ($MN)
Table 51 Global Endocrinology Market Analysis, by Manfacturing Process, 2013-2022 ($MN)
Table 52 Global Gastrointestinal Disorders Market Analysis, by Region, 2013-2022 ($MN)
Table 53 Global Gastrointestinal Disorders Market Analysis, by Drug Type, 2013-2022 ($MN)
Table 54 Global Gastrointestinal Disorders Market Analysis, by Type , 2013-2022 ($MN)
Table 55 Global Gastrointestinal Disorders Market Analysis, by Manfacturing Process, 2013-2022 ($MN)
Table 56 Global Other therapeutic area Market Analysis, by Region, 2013-2022 ($MN)
Table 57 Global Other therapeutic area Market Analysis, by Drug Type, 2013-2022 ($MN)
Table 58 Global Other therapeutic area Market Analysis, by Type , 2013-2022 ($MN)
Table 59 Global Other therapeutic area Market Analysis, by Manfacturing Process, 2013-2022 ($MN)
Table 60 Global Active Pharmaceutical Ingredient Market Analysis, by Type, 2013-2022 ($MN)
Table 61 Global Biological Market Analysis, by Region, 2013-2022 ($MN)
Table 62 Global Biological Market Analysis, by Drug Type, 2013-2022 ($MN)
Table 63 Global Biological Market Analysis, by Therapeutic Area, 2013-2022 ($MN)
Table 64 Global Biological Market Analysis, by Manfacturing Process, 2013-2022 ($MN)
Table 65 Global Synthetic Chemical Market Analysis, by Region, 2013-2022 ($MN)
Table 66 Global Synthetic Chemical Market Analysis, by Drug Type, 2013-2022 ($MN)
Table 67 Global Synthetic Chemical Market Analysis, by Therapeutic Area, 2013-2022 ($MN)
Table 68 Global Synthetic Chemical Market Analysis, by Manfacturing Process, 2013-2022 ($MN)
Table 69 Global Active Pharmaceutical Ingredient Market Analysis, by Manfacturing Process, 2013-2022 ($MN)
Table 70 Global Contract Manufacturing Market Analysis, by Region, 2013-2022 ($MN)
Table 71 Global Contract Manufacturing Market Analysis, by Drug Type, 2013-2022 ($MN)
Table 72 Global Contract Manufacturing Market Analysis, by Therapeutic Area, 2013-2022 ($MN)
Table 73 Global Contract Manufacturing Market Analysis, by Type, 2013-2022 ($MN)
Table 74 Global Captive Manufacturing Market Analysis, by Region, 2013-2022 ($MN)
Table 75 Global Captive Manufacturing Market Analysis, by Drug Type, 2013-2022 ($MN)
Table 76 Global Captive Manufacturing Market Analysis, by Therapeutic Area, 2013-2022 ($MN)
Table 77 Global Captive Manufacturing Market Analysis, by Type, 2013-2022 ($MN)
Note: Regional tables are presented in the similar manner as the above

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report